These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38294637)

  • 1. Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review.
    Singh E; Gurses ME; Costello MC; Berke C; Lu VM; Daggubati L; Komotar RJ; Ivan ME; Shah AH
    J Neurooncol; 2024 Mar; 167(1):39-47. PubMed ID: 38294637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-angiogenic therapy for high-grade glioma.
    Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal methotrexate in combination with systemic chemotherapy in glioblastoma patients with leptomeningeal dissemination: A retrospective analysis.
    Kang X; Chen F; Yang SB; Wang YL; Qian ZH; Li Y; Lin H; Li P; Peng YC; Wang XM; Li WB
    World J Clin Cases; 2022 Jun; 10(17):5595-5605. PubMed ID: 35979103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on the Efficacy and Safety of Intrathecal Administration of Novel Medications for Leptomeningeal Metastases in Solid Cancers.
    Jafari F; Nodeh MM; Hosseinjani H; Baharara H; Azad S; Arasteh O; Johnston TP; Sahebkar A
    Curr Med Chem; 2024; 31(19):2732-2750. PubMed ID: 37157199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
    Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
    J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosis.
    Witham TF; Fukui MB; Meltzer CC; Burns R; Kondziolka D; Bozik ME
    Cancer; 1999 Oct; 86(7):1347-53. PubMed ID: 10506724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rehabilitation Utilization by Cancer Patients with Pathology-Confirmed Leptomeningeal Disease Receiving Intrathecal Chemotherapy.
    Fu JB; Ng AH; Molinares DM; Pingenot EA; Morishita S; Silver JK; Bruera E
    Am J Phys Med Rehabil; 2021 Jan; 100(1):100-104. PubMed ID: 33534219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
    Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
    Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
    Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.
    Passarin MG; Moretto G; Musso AM; Ottaviani S; Masotto B; Ghimenton C; Iuzzolino P; Buffone E; Rudà R; Soffietti R; Vattemi E; Pedersini R
    J Neurooncol; 2010 May; 97(3):439-44. PubMed ID: 19876600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
    Zhong S; Fu X; Wu C; Liu R; Li S
    Neurosurg Rev; 2023 Nov; 46(1):311. PubMed ID: 37993665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptomeningeal disease in glioblastoma: endgame or opportunity?
    Akmal S; Ginalis EE; Patel NV; Aiken R; Dicpinigaitis AJ; Hanft SJ
    J Neurooncol; 2021 Nov; 155(2):107-115. PubMed ID: 34623599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Patients with Non-Small Cell Lung Cancer Leptomeningeal Disease Following Receipt of EGFR-Targeted Therapy, Immune-Checkpoint Blockade, Intrathecal Chemotherapy, or Radiation Therapy Alone.
    Mills MN; Uno A; Li P; Liveringhouse C; Kim Y; Oliver DE; Perez BA; Creelan BC; Yu M; Forsyth PA; Pina Y; Ahmed KA
    Clin Lung Cancer; 2024 Jul; 25(5):417-423.e1. PubMed ID: 38719648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
    Slavc I; Schuller E; Falger J; Günes M; Pillwein K; Czech T; Dietrich W; Rössler K; Dieckmann K; Prayer D; Hainfellner J
    J Neurooncol; 2003 Sep; 64(3):239-47. PubMed ID: 14558599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
    Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
    Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study of nivolumab for patients with recurrent high grade gliomas.
    Mantica M; Pritchard A; Lieberman F; Drappatz J
    J Neurooncol; 2018 Sep; 139(3):625-631. PubMed ID: 29779086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumab.
    Dietrich C; Salzmann M; Steinbrecher A; Herbst R; Hassel JC
    Immunotherapy; 2021 Sep; 13(13):1079-1083. PubMed ID: 34259028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.